Notwithstanding the fact that the expressed form of irisin remains unclear in humans, it has been the subject of many studies due to its proposed therapeutic potential for the treatment of obesity and obesity-associated maladies through browning of WAT. This evidence concerns the gene FNDC5 and obesity disorder.